Abstract:Background. Atherosclerosis is considered the most common cause of morbidity and mortality worldwide. Athermanous plaque formation is pathognomonic of atherosclerosis. The main feature of atherosclerosis is the formation of plaque, which is inseparable from endothelial cells, vascular smooth muscle cells, and macrophages. MicroRNAs, a small highly conserved noncoding ribonucleic acid (RNA) molecule, have multiple biological functions, such as regulating gene transcription, silencing target gene expression, and affecting protein translation. MicroRNAs also have various pharmacological activities, such as regulating cell proliferation, apoptosis, and metabolic processes. It is noteworthy that many studies in recent years have also proved that microRNAs play a role in atherosclerosis. Methods. To summarize the functions of microRNAs in atherosclerosis, we reviewed all relevant articles published in the PubMed database before June 2022, with keywords "atherosclerosis," "microRNA," "endothelial cells," "vascular smooth muscle cells," "macrophages," and "cholesterol homeostasis," briefly summarized a series of research progress on the function of microRNAs in endothelial cells, vascular smooth muscle cells, and macrophages and atherosclerosis. Results and Conclusion. In general, the expression levels of some microRNAs changed significantly in different stages of atherosclerosis pathogenesis; therefore, MicroRNAs may become new diagnostic biomarkers for atherosclerosis. In addition, microRNAs are also involved in the regulation of core processes such as endothelial dysfunction, plaque formation and stabilization, and cholesterol metabolism, which also suggests the great potential of microRNAs as a therapeutic target.

Noncoding RNAs in atherosclerosis: regulation and therapeutic potential

Non-coding RNA-Associated Therapeutic Strategies in Atherosclerosis

Non-coding RNAs are key players and promising therapeutic targets in atherosclerosis

Regulatory Roles of Related Long Non-coding RNAs in the Process of Atherosclerosis

Circular RNAs in the Pathogenesis of Atherosclerosis

Noncoding RNAs as therapeutic targets in atherosclerosis with diabetes mellitus

The Long Non-coding Road to Atherosclerosis

Targeting noncoding RNAs to treat atherosclerosis

Functional regulatory roles of microRNAs in atherosclerosis

Long Noncoding RNAs in Atherosclerosis.

The Combined Regulation of Long Non-coding RNA and RNA-Binding Proteins in Atherosclerosis

Non-Coding RNA Involved in the Pathogenesis of Atherosclerosis-A Narrative Review

LncRNA: An Important Regulator of Atherosclerosis

Circular RNA As Therapeutic Targets in Atherosclerosis: Are We Running in Circles?

Promising Directions in Atherosclerosis Treatment Based on Epigenetic Regulation Using MicroRNAs and Long Noncoding RNAs

MicroRNAs Regulate Function in Atherosclerosis and Clinical Implications

Long noncoding RNA/circular noncoding RNA-miRNA-mRNA axes in cardiovascular diseases

The regulation of circRNA and lncRNA protein binding in cardiovascular diseases: Emerging therapeutic targets

Anti-atherosclerosis mechanisms associated with regulation of non-coding RNAs by active monomers of traditional Chinese medicine

Targeting non-coding RNAs in unstable atherosclerotic plaques: Mechanism, regulation, possibilities, and limitations